The New Titans Of Finance
Capital One's acquisition of Discover Financial Services is reshaping the payments landscape, creating a larger, more competitive entity. This move signals a broader trend of consolidation in the financial sector, potentially benefiting other large banks and the payment technology firms that support them.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Capital One's $51.8 billion acquisition of Discover is creating a new financial giant and signaling a major consolidation wave across the payments industry. This merger demonstrates how large-scale integration is reshaping competitive dynamics, putting pressure on other banks to re-evaluate their strategic positions and potentially triggering more M&A activity.
What You Need to Know
This group focuses on companies positioned to benefit from the shifting financial landscape. It includes both established financial institutions that may be strategic targets or acquirers, and the critical technology firms that provide payment processing, data analytics, and software infrastructure essential for complex financial integrations.
Why These Stocks
These stocks were handpicked by professional analysts based on their potential to capitalize on the ongoing consolidation trend. The selection includes companies that either stand to benefit from increased M&A activity or provide the enabling technologies that make large-scale financial integrations possible.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+6.33%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 6.33% over the next year.
Stocks Rated Buy by Analysts
15 of 17 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.5% return last month.
Why You'll Want to Watch These Stocks
Merger Mania Is Here
Capital One's massive $51.8 billion Discover acquisition is just the beginning. This landmark deal is putting pressure on other major banks to make their own strategic moves, creating a wave of opportunities.
Tech Infrastructure Boom
When financial giants merge, they need serious technology to make it work. The companies that provide payment processing, data analytics, and integration software are seeing surging demand from these mega-deals.
Expert-Curated Winners
These aren't random picks. Professional analysts identified these specific companies as the ones best positioned to capitalize on the financial sector's transformation and consolidation trend.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.